Evidence map›Paper›PMID 24203341›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2014

The quality and validation of structures from structural genomics.

Marcin J Domagalski, Heping Zheng, Matthew D Zimmerman, Zbigniew Dauter, Alexander Wlodawer, Wladek Minor

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. CMM-An enhanced platform for interactive validation of metal binding sites.Protein science : a publication of the Protein Society · 2023
    Article
  8. 'International journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. A public database of macromolecular diffraction experiments.Acta crystallographica. Section D, Structural biology · 2016
    Article
  13. Article
  14. Review
  15. Single nucleotide variations: biological impact and theoretical interpretation.Protein science : a publication of the Protein Society · 2014
    Review
  16. Article
  17. The future of crystallography in drug discovery.Expert opinion on drug discovery · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcin J DomagalskiDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.
Heping Zheng
Matthew D Zimmerman
Zbigniew Dauter
Alexander Wlodawer
Wladek Minor

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
Midwest Center for Structural GenomicsU54GM094585 · NIGMS · UNIVERSITY OF CHICAGO · PI EDWARDS, ALED M · 2010 to 2014
$33.7M
The NYSGRC: A Large Scale Center for PSI:BiologyU54GM094662 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI FISER, ANDRAS · 2010 to 2014
$32.6M
Protein StructureZIABC010348 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WLODAWER, ALEXANDER · 2009 to 2025
$27.5M
Macromolecular Crystallography Research with Synchrotron RadiationZIABC010378 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DAUTER, ZBIGNIEW · 2009 to 2020
$18.8M
X-RAY CRYSTALLOGRAPHY OF MACROMOLECULESR01GM053163 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI MINOR, WLADEK, OTWINOWSKI, ZBYSZEK · 1996 to 2014
$6.3M
Intramural NIH HHSNCI NIH HHS P30 CA044579NIAID NIH HHS HHSN272201200026CNIGMS NIH HHS R01 GM053163NIGMS NIH HHS U54 GM094585NIGMS NIH HHS U54 GM094662
6 · The paper itself

Abstract

Quality control of three-dimensional structures of macromolecules is a critical step to ensure the integrity of structural biology data, especially those produced by structural genomics centers. Whereas the Protein Data Bank (PDB) has proven to be a remarkable success overall, the inconsistent quality of structures reveals a lack of universal standards for structure/deposit validation. Here, we review the state-of-the-art methods used in macromolecular structure validation, focusing on validation of structures determined by X-ray crystallography. We describe some general protocols used in the rebuilding and re-refinement of problematic structural models. We also briefly discuss some frontier areas of structure validation, including refinement of protein-ligand complexes, automation of structure redetermination, and the use of NMR structures and computational models to solve X-ray crystal structures by molecular replacement.

Indexed as

Protein ConformationDatabases, ProteinData MiningLigandsMacromolecular SubstancesModels, MolecularNuclear Magnetic Resonance, BiomolecularProtein BindingProteinsProteomicsQuality ControlReproducibility of ResultsLigandsMacromolecular SubstancesProteins

Identifiers

PMID24203341
PMCPMC4081469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.